The cell proliferative factors in aortic valves are upregulated by growth factors, such as transforming growth factors, fibroblast growth factors, or epidermal growth factors, which are abnormally increased in CAVD (Wu et al., 2017; Cho et al., 2018). Here, EGF is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.